BACKGROUND: It has been suggested that cystatin C may be a superior measure of estimated glomerular filtration rate (eGFR) than creatinine-based methods. We aimed to assess the utility of cystatin C for clinical triage in community-based settings. METHODS: We identified cystatin C thresholds that maximize sensitivity and specificity (Max(Sn + Sp)) for predicting death and subsequently applied classification tree methodology considering serum creatinine, creatinine-based eGFR, urinary albumin-creatinine ratio and conventional modifiable risk factors to define subgroups, interactions and hierarchical ranks in fasting US adults (National Health and Nutrition Examination Survey 1988-94, followed through 2006). RESULTS: A threshold cystatin C value of 0.94 mg/L exhibited the best maximum combined value of sensitivity and specificity for predicting death (Max(Sn + Sp), Sn 0.64/Sp 0.78). When all variables were considered jointly in a classification tree, cystatin C and albumin-creatinine ratio were the primary mortality discriminators in subgroups that added up to 41 and 14% of the study population, respectively; serum creatinine and creatinine-based eGFR were non-discriminatory. CONCLUSION: Cystatin C may be useful for risk-based clinical triage in public health settings.
BACKGROUND: It has been suggested that cystatin C may be a superior measure of estimated glomerular filtration rate (eGFR) than creatinine-based methods. We aimed to assess the utility of cystatin C for clinical triage in community-based settings. METHODS: We identified cystatin C thresholds that maximize sensitivity and specificity (Max(Sn + Sp)) for predicting death and subsequently applied classification tree methodology considering serum creatinine, creatinine-based eGFR, urinary albumin-creatinine ratio and conventional modifiable risk factors to define subgroups, interactions and hierarchical ranks in fasting US adults (National Health and Nutrition Examination Survey 1988-94, followed through 2006). RESULTS: A threshold cystatin C value of 0.94 mg/L exhibited the best maximum combined value of sensitivity and specificity for predicting death (Max(Sn + Sp), Sn 0.64/Sp 0.78). When all variables were considered jointly in a classification tree, cystatin C and albumin-creatinine ratio were the primary mortality discriminators in subgroups that added up to 41 and 14% of the study population, respectively; serum creatinine and creatinine-based eGFR were non-discriminatory. CONCLUSION:Cystatin C may be useful for risk-based clinical triage in public health settings.
Authors: Andrew S Levey; Kai-Uwe Eckardt; Yusuke Tsukamoto; Adeera Levin; Josef Coresh; Jerome Rossert; Dick De Zeeuw; Thomas H Hostetter; Norbert Lameire; Garabed Eknoyan Journal: Kidney Int Date: 2005-06 Impact factor: 10.612
Authors: Mark J Sarnak; Ronit Katz; Catherine O Stehman-Breen; Linda F Fried; Nancy Swords Jenny; Bruce M Psaty; Anne B Newman; David Siscovick; Michael G Shlipak Journal: Ann Intern Med Date: 2005-04-05 Impact factor: 25.391
Authors: Michael G Shlipak; Mark J Sarnak; Ronit Katz; Linda F Fried; Stephen L Seliger; Anne B Newman; David S Siscovick; Catherine Stehman-Breen Journal: N Engl J Med Date: 2005-05-19 Impact factor: 91.245
Authors: Robert N Foley; Anne M Murray; Shuling Li; Charles A Herzog; A Marshall McBean; Paul W Eggers; Allan J Collins Journal: J Am Soc Nephrol Date: 2004-12-08 Impact factor: 10.121
Authors: Stephen L Seliger; W T Longstreth; Ronit Katz; Teri Manolio; Linda F Fried; Michael Shlipak; Catherine O Stehman-Breen; Anne Newman; Mark Sarnak; Daniel L Gillen; Anthony Bleyer; David S Siscovick Journal: J Am Soc Nephrol Date: 2005-10-19 Impact factor: 10.121
Authors: Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson Journal: Circulation Date: 2003-10-28 Impact factor: 29.690
Authors: William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule Journal: Mayo Clin Proc Date: 2016-10-21 Impact factor: 7.616
Authors: Marissa E Sakoda; Pariya L Fazeli; Ronald J Ellis; Dilip V Jeste; Igor Grant; Scott L Letendre; David J Moore Journal: J Acquir Immune Defic Syndr Date: 2017-03-01 Impact factor: 3.731